Small ruminant lentiviruses (SRLV) are chronic and progressive diseases that compromise production, health and animal welfare. Due to the lack of cure, vaccines or any effective treatments against SRLV, homeopathy emerges as a low-cost and residue-free approach. This study sought to evaluate the effect of two homeopathic interventions following a triple-blind, placebo-controlled protocol to treat goats displaying SRLV. A total of 42 adult Saanen goats (4.6 ± 1.3 years old; 2.6 ± 0.2 body condition score [BCS]; 59.5 ± 8.7 kg) with chronic arthritis and weight loss were included in this study after infection confirmation by PCR and seropositivity by Western Blot to SRLV. The following experimental groups were organized: SRLV living nosode (Gnosode; n=14), Homeopathic (Ghomeopathic; n=14) and Placebo (Gplacebo; n=14). Treatments were administered daily, orally, for 90 days. Every month, all goats underwent a clinical examination, joint ultrasound and collection of production indices. There was a treatment effect (p≤0.05) for productive (BCS and live weight) and clinical indices (clinical articular index, crepitation and width indices). Gnosode and Ghomeopathic showed a greater BCS when compared to Gplacebo (2.7±0.3 = 2.8±0.4 ≠ 2.5±0.3). Ghomeopathic had a greater live weight compared to Gplacebo, even though equal to Gnosode (62.4±11.2 ≠ 57.2±9.5 = 60.4±9.8 kg). In clinical evaluations, Gnosode obtained lower carpal joint indices when compared to Gplacebo, even though equal to Ghomeopathic (8.2±1.7 ≠ 8.7±1.0 = 8.5±1.4 cm). There was also an improvement (p≤0.05) for joint ultrasound indices (sagittal and transverse section of the carpus, distance from the joint capsule to the subchondral space, area and lesion perimeter). Such indices obtained lower values in both treated groups (Gnosode and Ghomeopathic) when compared to Gplacebo as highlighted for the distance from the joint capsule to the subchondral space (6.9±3.3 = 7.6±3.4 ≠ 10.8±4.4 mm), area (137.5±84.4 = 157.9±89.1 ≠ 235.0±90.1 mm) and joint lesion perimeter (81.8±18.8 = 85.7±17.6 ≠ 101.5±15.9 mm). Comparing the joint lesion area from D0 to D90, there was a reduction by more than 50% in both treated groups with an increase of 37.2% in Gplacebo. In conclusion, Gnosode and Ghomeopathic demonstrated promising outcomes improving arthritic lesions and production rates. Therefore, both medicines, can be safely used in goats infected with SRLV displaying chronic arthritis and weight loss.
Read full abstract